Literature DB >> 23774212

mTOR signaling feedback modulates mammary epithelial differentiation and restrains invasion downstream of PTEN loss.

Susmita Ghosh1, Lidenys Varela, Akshay Sood, Ben Ho Park, Tamara L Lotan.   

Abstract

Oncogenic signaling pathways are tightly regulated by negative feedback circuits and relief of these circuits represents a common mechanism of tumor drug resistance. Although the significance of these feedback pathways for signal transduction is evident, their relevance for cellular differentiation and morphogenesis in a genetically defined context is unclear. In this study, we used isogenic benign mammary organotypic cultures to interrogate the role of mTOR-mediated negative feedback in the specific setting of PTEN inactivation. We found that mTOR signaling promoted basal-like differentiation and repressed nuclear hormone receptor expression after short-term PTEN loss in murine cell cultures analyzed ex vivo. Unexpectedly, we found that PTEN inactivation inhibited growth factor-induced epithelial invasion and that downstream mTOR-mediated signaling feedback was both necessary and sufficient for this effect. Mechanistically, using isogenic MCF10A cells with and without somatic PTEN deletion, we showed that mTOR inhibition promoted EGF-mediated epithelial invasion by derepressing upstream EGF receptor, SRC tyrosine kinase, and phosphoinositide 3-kinase signaling. In addition to offering new signal transduction insights, these results bring to light a number of important and potentially clinically relevant cellular consequences of mTOR inhibition in the specific context of PTEN loss, including modulation of hormone and growth factor responsiveness and promotion of epithelial invasion. Our findings prompt future investigations of the possibility that mTOR inhibitor therapy may not only be ineffective but even deleterious in tumors with PTEN loss.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23774212      PMCID: PMC3767295          DOI: 10.1158/0008-5472.CAN-13-0429

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  45 in total

1.  Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures.

Authors:  Jayanta Debnath; Senthil K Muthuswamy; Joan S Brugge
Journal:  Methods       Date:  2003-07       Impact factor: 3.608

2.  Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2.

Authors:  Brendan D Manning; M Nicole Logsdon; Alex I Lipovsky; Derek Abbott; David J Kwiatkowski; Lewis C Cantley
Journal:  Genes Dev       Date:  2005-07-18       Impact factor: 11.361

3.  A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells.

Authors:  David J Kwiatkowski; Hongbing Zhang; Jennifer L Bandura; Kristina M Heiberger; Michael Glogauer; Nisreen el-Hashemite; Hiroaki Onda
Journal:  Hum Mol Genet       Date:  2002-03-01       Impact factor: 6.150

Review 4.  Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis.

Authors:  Corinne M Silva
Journal:  Oncogene       Date:  2004-10-18       Impact factor: 9.867

5.  Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin.

Authors:  Mark D Sternlicht; Susan W Sunnarborg; Hosein Kouros-Mehr; Ying Yu; David C Lee; Zena Werb
Journal:  Development       Date:  2005-08-03       Impact factor: 6.868

6.  Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies.

Authors:  O Jameel Shah; Zhiyong Wang; Tony Hunter
Journal:  Curr Biol       Date:  2004-09-21       Impact factor: 10.834

7.  PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.

Authors:  Yoichi Nagata; Keng-Hsueh Lan; Xiaoyan Zhou; Ming Tan; Francisco J Esteva; Aysegul A Sahin; Kristine S Klos; Ping Li; Brett P Monia; Nina T Nguyen; Gabriel N Hortobagyi; Mien-Chie Hung; Dihua Yu
Journal:  Cancer Cell       Date:  2004-08       Impact factor: 31.743

8.  Reduced PTEN expression predicts relapse in patients with breast carcinoma treated by tamoxifen.

Authors:  Nael Shoman; Shannon Klassen; Andrew McFadden; Miķelis G Bickis; Emina Torlakovic; Rajni Chibbar
Journal:  Mod Pathol       Date:  2005-02       Impact factor: 7.842

9.  Oncogenic and wild-type Ras play divergent roles in the regulation of mitogen-activated protein kinase signaling.

Authors:  Amy Young; David Lou; Frank McCormick
Journal:  Cancer Discov       Date:  2012-10-25       Impact factor: 39.397

10.  The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins.

Authors:  Laura S Harrington; Greg M Findlay; Alex Gray; Tatiana Tolkacheva; Simon Wigfield; Heike Rebholz; Jill Barnett; Nick R Leslie; Susan Cheng; Peter R Shepherd; Ivan Gout; C Peter Downes; Richard F Lamb
Journal:  J Cell Biol       Date:  2004-07-12       Impact factor: 10.539

View more
  8 in total

1.  Synthetic Essentiality of Metabolic Regulator PDHK1 in PTEN-Deficient Cells and Cancers.

Authors:  Nilanjana Chatterjee; Evangelos Pazarentzos; Manasi K Mayekar; Philippe Gui; David V Allegakoen; Gorjan Hrustanovic; Victor Olivas; Luping Lin; Erik Verschueren; Jeffrey R Johnson; Matan Hofree; Jenny J Yan; Billy W Newton; John V Dollen; Charles H Earnshaw; Jennifer Flanagan; Elton Chan; Saurabh Asthana; Trey Ideker; Wei Wu; Junji Suzuki; Benjamin A Barad; Yuriy Kirichok; James S Fraser; William A Weiss; Nevan J Krogan; Asmin Tulpule; Amit J Sabnis; Trever G Bivona
Journal:  Cell Rep       Date:  2019-08-27       Impact factor: 9.423

2.  mTORC1 loss impairs epidermal adhesion via TGF-β/Rho kinase activation.

Authors:  Kaushal Asrani; Akshay Sood; Alba Torres; Dan Georgess; Pornima Phatak; Harsimar Kaur; Amber Dubin; C Conover Talbot; Loubna Elhelu; Andrew J Ewald; Bo Xiao; Paul Worley; Tamara L Lotan
Journal:  J Clin Invest       Date:  2017-09-25       Impact factor: 14.808

3.  p53 Maintains Baseline Expression of Multiple Tumor Suppressor Genes.

Authors:  Kyrie Pappas; Jia Xu; Sakellarios Zairis; Lois Resnick-Silverman; Francesco Abate; Nicole Steinbach; Sait Ozturk; Lao H Saal; Tao Su; Pamela Cheung; Hank Schmidt; Stuart Aaronson; Hanina Hibshoosh; James Manfredi; Raul Rabadan; Ramon Parsons
Journal:  Mol Cancer Res       Date:  2017-05-08       Impact factor: 5.852

4.  LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition.

Authors:  Qingsong Hu; Chunlai Li; Shouyu Wang; Yajuan Li; Bo Wen; Yanyan Zhang; Ke Liang; Jun Yao; Youqiong Ye; Heidi Hsiao; Tina K Nguyen; Peter K Park; Sergey D Egranov; David H Hawke; Jeffrey R Marks; Leng Han; Mien-Chie Hung; Bing Zhang; Chunru Lin; Liuqing Yang
Journal:  Cell Res       Date:  2019-01-10       Impact factor: 25.617

5.  PTEN is required to maintain luminal epithelial homeostasis and integrity in the adult mammary gland.

Authors:  Amy N Shore; Chi-Hsuan Chang; Oh-Joon Kwon; Matthew C Weston; Mei Zhang; Li Xin; Jeffrey M Rosen
Journal:  Dev Biol       Date:  2015-10-23       Impact factor: 3.582

6.  DAPK3 suppresses acini morphogenesis and is required for mouse development.

Authors:  Brandon A Kocher; Lynn S White; David Piwnica-Worms
Journal:  Mol Cancer Res       Date:  2014-10-10       Impact factor: 5.852

7.  Anti-protozoal and anti-bacterial antibiotics that inhibit protein synthesis kill cancer subtypes enriched for stem cell-like properties.

Authors:  Elisabet Cuyàs; Begoña Martin-Castillo; Bruna Corominas-Faja; Anna Massaguer; Joaquim Bosch-Barrera; Javier A Menendez
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 8.  Disruption of prostate epithelial differentiation pathways and prostate cancer development.

Authors:  Sander B Frank; Cindy K Miranti
Journal:  Front Oncol       Date:  2013-10-31       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.